Aerosol Administration of a Recombinant Adenovirus Expressing CFTR to Cystic Fibrosis Patients: A Phase I Clinical Trial

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Modification of Nasal Epithelial Potential Differences of Individuals with Cystic Fibrosis Consequent to Local Administration of a Normal CFTR cDNA Adenovirus Gene Transfer Vector1995 · 135 citations
2. 2Airway and lung elastic fibre is not reduced in asthma nor in asthmatics following corticosteroid treatment1995 · 41 citations
3. 3Intrathecal Gene Therapy for the Treatment of Leptomeningeal Carcinomatosis. National Institutes of Health, Bethesda, Maryland1995 · 37 citations
4. 4The cystic fibrosis gene has a “housekeeping”-type promoter and is expressed at low levels in cells of epithelial origin1991 · 177 citations
5. 5In Vivo Nasal Potential Difference: Techniques and Protocols for Assessing Efficacy of Gene Transfer in Cystic Fibrosis1995 · 310 citations